Skye Bioscience, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
SKYE on Nasdaq
Industry
Pharmaceutical Preparations
Location
11250 El Camino Real, Suite 100, San Diego, CA

Insiders trading volume in the past year

Skye Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Andrew J. Schwab Director, 10%+ Owner $102M Mar 13, 2024
5AM Partners VII, LLC 10%+ Owner $102M +$16.5M +19.4% Mar 13, 2024
Versant Ventures III, LLC 10%+ Owner $9.39M Aug 18, 2023
Punit Dhillon Chief Executive Officer, Director $4.22M Aug 26, 2024
Emerald Health Sciences Inc. 10%+ Owner $3.17M Nov 10, 2022
Paul A. Grayson Director $800K Feb 29, 2024
Kaitlyn Arsenault Chief Financial Officer $486K Feb 29, 2024
Tuan Tu Diep Chief Development Officer $237K Feb 29, 2024
Sukhwinder Singh Rai Director $6.04K Jan 5, 2023
Puneet S. Arora Chief Medical Officer $3.83K Sep 3, 2024
Annalisa Jenkins Director $680 Feb 29, 2024
Deborah H. Charych Director $595 Feb 29, 2024
Margaret Dalesandro Director $595 Feb 29, 2024
Keith Wayne Ward Director $595 Feb 29, 2024
Praveen Tyle Director $595 Feb 29, 2024
James L. Heppell Director Sep 14, 2021
Karen L. Smith Director Jul 2, 2024

Recent Insider Transactions by Companies or Individuals for Skye Bioscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.